You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 22, 2024

~ Buy the BEVESPI AEROSPHERE (formoterol fumarate; glycopyrrolate) Drug Profile, 2024 PDF Report in the Report Store ~

CLINICAL TRIALS PROFILE FOR BEVESPI AEROSPHERE


✉ Email this page to a colleague

« Back to Dashboard


All Clinical Trials for BEVESPI AEROSPHERE

Trial ID Title Status Sponsor Phase Start Date Summary
NCT03081156 ↗ The Effect of BEVESPI AEROSPHERE ® Therapy on Exercise Tolerance in COPD Completed Los Angeles Biomedical Research Institute Phase 4 2017-03-27 This trial is an investigator initiated study involving the use of the AstraZenica Aerophere Inhaler (Glycopyrrolate/Formoterol) to determine the effect on exercise tolerance and dynamic hyperinflation in patients with chronic obstructive lung disease.
NCT03081156 ↗ The Effect of BEVESPI AEROSPHERE ® Therapy on Exercise Tolerance in COPD Completed Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center Phase 4 2017-03-27 This trial is an investigator initiated study involving the use of the AstraZenica Aerophere Inhaler (Glycopyrrolate/Formoterol) to determine the effect on exercise tolerance and dynamic hyperinflation in patients with chronic obstructive lung disease.
NCT03324607 ↗ Effects of Bevespi on Ventilation and Gas Exchange Abnormalities in COPD Assessed by 129Xe MRI Completed Bastiaan Driehuys Phase 2/Phase 3 2018-04-20 The purpose of this study is to determine whether the new inhaler, Bevespi improves lung function. Magnetic resonance imaging (MRI) using inhaled hyperpolarized 129Xe gas, that can provide useful images of the functioning of the lung will be used as a new measure to determine change in function. The investigator anticipate these images will provide more specific information about lung disease than standard lung function tests in response to treatment.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for BEVESPI AEROSPHERE

Condition Name

Condition Name for BEVESPI AEROSPHERE
Intervention Trials
COPD 1
Pulmonary Disease, Chronic Obstructive 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for BEVESPI AEROSPHERE
Intervention Trials
Congenital Abnormalities 1
Pulmonary Disease, Chronic Obstructive 1
Lung Diseases, Obstructive 1
Lung Diseases 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for BEVESPI AEROSPHERE

Trials by Country

Trials by Country for BEVESPI AEROSPHERE
Location Trials
United States 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for BEVESPI AEROSPHERE
Location Trials
North Carolina 1
California 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for BEVESPI AEROSPHERE

Clinical Trial Phase

Clinical Trial Phase for BEVESPI AEROSPHERE
Clinical Trial Phase Trials
Phase 4 1
Phase 2/Phase 3 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for BEVESPI AEROSPHERE
Clinical Trial Phase Trials
Completed 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for BEVESPI AEROSPHERE

Sponsor Name

Sponsor Name for BEVESPI AEROSPHERE
Sponsor Trials
Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center 1
Bastiaan Driehuys 1
Los Angeles Biomedical Research Institute 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for BEVESPI AEROSPHERE
Sponsor Trials
Other 3
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.